TLR1 and lung carcinoma: The Pan-Lung Cancer panel (n=1089 patients both ADC and squamous cell carcinoma) demonstrated low somatic mutation, deletion and amplification rates for TLR1, 2, 6, 9, and 10, however for each of the other TLRs, one of these molecular alterations was > 2% ≤ 10%, see Supplementary Table 4A.